Burkina Faso received on Sunday evening, May 30, some 115,000 doses of AstraZeneca vaccines against Covid-19 funded by the Covax device, which will allow this poor West African country to start a first on June 2 vaccination phase.
“It is with satisfaction that we welcome the first doses of vaccine against Covid-19 in Burkina Faso. Thanks to scientific progress, we now have another arsenal which completes the fight system ”, said Burkinabe Minister of Health Charlemagne Ouédraogo, after receiving 115,200 doses at Ouagadougou international airport.
“There are several types of vaccines, but the first that we receive this evening from the Covax mechanism, are the Astra Zeneca vaccine. This vaccine has already been deployed in several countries and it is Burkina’s turn to receive it so that our system is completed ”, he clarified.
For those most at risk
The Covax program was set up to provide low-income countries with a significant supply of Covid-19 vaccines. These first vaccines will be distributed throughout the country and vaccinations should begin Wednesday on those most at risk, Mr. Ouédraogo told AFP.
According to the Ministry of Health, “The targets concerned by this first phase are health personnel, people living with co-morbidities [hypertension, diabète, insuffisance rénale…] and the candidates for the pilgrimage to Mecca ”.
Thanks to Covax, Burkina Faso intends initially to vaccinate 3% of the population to gradually reach 20%, or 4,341,233 people out of a total population estimated at more than 20 million. Then, with the support of its partners, it aims to vaccinate 50% of the remaining population. A total of 9,857,963 people are expected to be vaccinated at term.
The country, which has 13,430 cases of coronavirus for 166 deaths, was one of the last in West Africa not to launch its vaccination campaign against the pandemic.